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Summary 
The mitogen-induced lymphocyte proliferative response and its sensitivity to in vitro (lO-‘O-lO-h Ml 
dexamethasone (DEX) administration were investigated in 12 severely depressed patients and 13 healthy 
controls. Patients with major depressive disorder exhibited no impairment of lectin-induced blastogene- 
sis, but a significantly weaker suppressive effect of in vitro DEX on 1.0 pg/ml phytohemagglutinin 
A-induced proliferation. The inhibitory potency of in vitro DEX was inversely correlated with in vivo 
adrenal cortical hormone levels at 4.00 p.m. These effects were not observed with pokeweed mitogen- 
and concanavalin A-stimulated cells. There were no correlations with age, weight, sex or severity of 
depression. These results do not support the hypothesis of a primarily impaired cell-mediated immunity, 
but might be indicative of reduced glucocorticoid receptor sensitivity in major depressive disorder. 
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Cell-mediated immunity 
Introduction 
In recent years, knowledge about the interac- 
tions between the brain, behavior and immunity 
has expanded rapidly (Ader et al., 1990). One 
well-studied mechanism of nervous system influ- 
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ence on the immune system is regulation via 
adrenal cortical hormones. Both the experience 
of stressful life events and the syndrome of de- 
pression have been associated with alterations in 
circulating concentrations of glucocorticoids, as 
well as alterations in immune function (Calabrese 
et al., 1987; Irwin et al., 1987). 
During acute depressive illness approximately 
50% of patients were shown to have increased 
hypothalamic-pituitary-adrenal (HPA) axis activ- 
ity, e.g., excess cortisol production and resistance 
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to dexamethasone suppression (Carroll et al., 
1968; Linkowski et al., 1985). Nevertheless, they 
fail to display clinical signs of Cushing’s syn- 
drome. 
There might be a simple explanation for this 
phenomenon, such as a different duration and 
magnitude of hypercortisolism as compared to 
Cushing’s syndrome. Since a variety of hormones 
are reported to be resistant to glucocorticoid-in- 
duced changes, e.g., adrenocorticotropic hormone 
(ACTH), P-endorphin and prolactin (Fang et al., 
1981; Rupprecht et al., 1987, 1988), a glucocorti- 
coid receptor dysfunction in major depressive dis- 
order might be hypothesized. This again should 
have some effects on immune system integrity, 
since peripheral blood mononuclear cells possess 
glucocorticoid receptors and are sensitive to glu- 
cocorticoids (Cupps and Fauci, 1982). 
Usually in vivo pharmacologic doses of gluco- 
corticoids inhibit antigen- and mitogen-induced T 
lymphocyte proliferation and lymphokine produc- 
tion. In contrast, B lymphocytes are known to be 
sensitive to the suppressive effects of glucocorti- 
coids only in the early activation phase of the cell 
cycle (Cupps and Fauci, 1982; Bowen and Fauci, 
1984). 
Most frequently, the mitogen response assay 
was used to determine the capacity of T and B 
lymphocytes to respond to antigens, i.e., the in- 
tegrity of cell-mediated immunity. The commonly 
used lectins concanavalin A (Con A) and phyto- 
hemagglutinin A (PHA) are known to stimulate T 
lymphocytes quite selectively, whereas pokeweed 
mitogen (PWM) induces an accessory cell-depen- 
dent B lymphocyte proliferation (Rosenberg and 
Lipsky, 1979; Cupps and Fauci, 1982). Some 
groups have reported a significantly lower re- 
sponse to these lectins in lymphocytes of de- 
pressed patients compared to various control 
groups (Schleifer et al., 1984; Calabrese et al., 
1986; Kronfol et al., 1986; Cosyns et al., 1989). 
Other investigators were not able to replicate 
these findings (Albrecht et al., 1985; Darko et al., 
1989; Schleifer et al., 1989) or even described an 
increase in response to PHA (Altshuler et al., 
1989). Lowy et al. (1988) did not find any differ- 
ences in basal lymphocyte responses between 
healthy controls, depressed and non-depressed 
psychiatric patients. Instead, they described a de- 
creased glucocorticoid sensitivity of Con A- 
stimulated lymphocytes in depressed patients, 
who exhibited a positive dexamethasone suppres- 
sion test (DsT). 
Despite its sensitivity to in vivo and in vitro 
glucocorticoids, the lectin-induced immune re- 
sponses showed no correlation with the levels of 
circulating adrenal cortical hormones (Dark0 et 
al., 1989; Kronfol and House, 1989; Schleifer et 
al., 19891, nor with urinary free cortisol (Kronfol 
et al., 1986). But it has to be noticed that these 
studies differed quite considerably in methodol- 
ogy (e.g., concentrations of lectins, incubation 
period), as well as selection criteria of patients 
(e.g., diagnostic criteria, severity of depression, 
medication, age, sex). 
This study addresses the following questions. 
(1) Is major depression (according to DSM-IIIR) 
associated with an impaired cell-mediated immu- 
nity? (2) Is major depression associated with an 
impairment of normal sensitivity of cell-mediated 
immunity to glucocorticoids? (3) Are the results 
associated with circulating concentrations of 
adrenal cortical hormones, such as cortisol and 
ACTH? (4) Are the results affected by the sever- 
ity of depression or by several other variables, 
such as gender, age, weight? 
Methods 
Patients 
Twelve subjects (mean age + SD: 48.7 t_ 15.1 
years; mean body weight f SD: 72.5 + 13.4 kg), 
admitted to the psychiatric clinic of the Univer- 
sity of Wiirzburg with severe unipolar major de- 
pressive disorder or bipolar depression (according 
to DSM-IIIR) and 13 non-hospitalized healthy 
controls, closely matched for age, sex and weight 
(mean age + SD: 47.4 f 6.4 years; mean body 
weight i SD: 69.2 + 8.6 kg) were studied. Four 
female depressives and the matched controls were 
tested during the midluteal phase of the cycle, 
the other females were postmenopausal. 
All subjects were carefully screened for nutri- 
tional status and prevalence of medical illness, as 
well as alcohol or nicotine abuse and stressful life 
events that might influence pituitary-adrenal or 
immune system function, by medical history, 
physical examination and routine laboratory in- 
vestigation. 
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All patients were drug-free for at least 4 days 
prior to investigation, and seven patients for more 
than 3 weeks. DSM-IIIR (American Psychiatric 
Association, 1987) diagnoses were made indepen- 
dently by two psychiatrists, who were blind to 
laboratory investigations. Severity of depression 
was assessed on the day of laboratory investiga- 
tion using the 21-item Hamilton Rating Scale for 
Depression (HRS-D; Hamilton, 1960). 
Controls had no history of psychiatric disorder, 
nor had they relatives with a psychiatric illness. 
They were free of any medication and their HRS- 
D scores were below 5. 
Written informed consent was obtained from 
all subjects prior to the investigation. This study 
was approved by the ethical committee of the 
University of Wiirzburg. 
Assays 
All subjects were admitted to a sleep labora- 
tory unit at least 1 h prior to blood sampling. For 
determination of hormonal values and lympho- 
cyte proliferation parameters 50 ml venous blood 
was collected at 4.00 p.m. into plastic tubes con- 
taining EDTA. 
Preparation of cells 
Peripheral blood mononuclear cells (PBMC) 
were prepared from EDTA blood under sterile 
conditions by sodium metrizoate-Ficoll density 
gradient centrifugation as described previously 
(Rupprecht et al., 1990). Briefly, cells were 
washed twice in phosphate-buffered saline (PBS) 
at 100 x g for 10 min and incubated for 60 min at 
37°C followed by a third washing procedure. The 
final cell count was performed with a Coulter 
counter (Model S5, Coulter Electronics Ltd, Eng- 
land). The viability of cells exceeded 95%, as 
judged from their ability to exclude trypan blue 
(Pappenheimer, 1917). Contamination by granu- 
locytes and monocytes was always less than 8%. 
Cell culture 
PBMC were suspended at a concentration of 
2.5 x 104/well in culture medium (see Chemi- 
cals) and incubated in triplicate in 96-well mi- 
crotiter plates (0.2 ml/well; NUNC, Sweden) for 
60 h to evaluate Con A- and PHA-generated T 
cell proliferation and for 132 h to evaluate 
PWM-generated accessory cell-dependent B cell 
proliferation in a sterile, humidified atmosphere 
(5% CO,/95% air). To determine lectin dose-re- 
sponse curves, Con A and PWM were added at 
final concentrations of 0.5, 1.0, 5.0, 10.0, 20.0, 
40.0 and 50.0 pg/ml, PHA at 0.1, 0.5, 1.0, 2.5, 
5.0, 10.0 and 20.0 pg/ml. Eventually, lectin-in- 
duced DNA synthesis in lymphocytes was ana- 
lyzed at one optimal and one non-optimal con- 
centration of each lectin (Table 2). To assess in 
vitro glucocorticoid sensitivity, 10-‘O-lO~h mol/l 
dexamethasone (DEX) was added to spontaneous 
(without lectin) and mitogen-stimulated lympho- 
cyte cultures. Again one optimal and one non-op- 
timal concentration of each lectin were used for 
mitogen-stimulated lymphocyte cultures. 
To measure DNA synthesis 0.5 PCi [“Hlthymi- 
dine was added 5 h prior to termination of the 
incubation period. Incorporation of [ ‘Hlthymi- 
dine was assessed by rapid filtration through 
Whatman GF/B filters (Whatman, Maidstone, 
U.K.) with a Titertek semi-automatic cell har- 
vester (Flow Laboratories, Inc., Rockville, MD, 
U.S.A.) by a 11-s wash with distilled water at 
room temperature. The radioisotope was mea- 
sured by standard liquid scintillation counting in 
a Beckman LS 5000 TD counter at about 54% 
efficiency. All samples were assayed in triplicate. 
The coefficient of variation was always less than 
15%. 
Serum hormone determinations 
ACTH was measured by a newly developed 
immunoradiometric assay (IRMA) supplied by 
the Nichols Institute (San Juan Capistrano, CA, 
U.S.A.; Raff and Findling, 1989). The lower de- 
tection limit was 1.5 pmol/l, and the intra- and 
interassay coefficients of variation were 3% and 
6.8%, respectively. 
Cortisol was measured by a direct radioim- 
munoassay (RIA) (Stalla et al., 1981). The lower 
detection limit was 25 nmol/l, and the intra- and 
interassay coefficients of variation were 5% and 
9%, respectively. 
Chemicals 
[ 3H]Thymidine was obtained from Amersham, 
U.K. Phosphate-buffered saline (PBS) was ob- 
tained from Boehringer (Mannheim, F.R.G.). 
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Concanavalin A (Con A), phytohemagglutinin A 
(PHA), pokeweed mitogen (PWM), dexametha- 
sane and sodium metrizoate-Ficoll were ob- 
tained from Sigma (St. Louis, MO, U.S.A.), and 
Rotiszint 22 was obtained from Roth (Karlsruhe, 
F.R.G.). Con A, PHA, PWM and dexamethasone 
were diluted to the respective final concentra- 
tions with culture medium. The culture medium 
consisted of RPM1 1640 (Boehringer, Mannheim, 
F.R.G.) supplemented with 2 mM L.-glutamate 
(Biochrom, Berlin, F.R.G.), 0.1 mg/ml genta- 
micin (Biochrom, Berlin, F.R.G.) and 10% fetal 
calf serum (FCS, Biochrom, Berlin, F.R.G.). The 
same lots of lectins and FCS were used through- 
out the whole investigation to limit methodologi- 
cal variation. 
Statistical analysis 
Lymphocyte proliferation was expressed in 
terms of a stimulation index (SI) defined by the 
ratio of stimulated (in the presence of lectin) 
counts per minute (cpm) to spontaneous (in the 
absence of lectin) cpm. The results are mean + 
SD, unless otherwise stated. Hormone values be- 
low the detection limit of our assays were 
recorded as the respective detection limits. Data 
were analyzed using Pearson’s product-moment 
correlation, one-way analysis of variance 
(ANOVA), and analysis of covariance (ANCO- 
VA). All significance levels are two-tailed. 
Results 
Cell (‘iability 
Under the culture conditions of the lympho- 
cyte proliferation assays, the mean cell viabilities 
at the time of harvest (day 3 and day 5) were 
97.0% + 1.3% and 94.8% f 2.5%, respectively. 
Descriptir’e statistics 
Table 1 summarizes the demographic and clin- 
ical data of the 12 depressive patients studied. 
There were no significant differences in age, 
weight or hormone values between the controls 
and depressed patients investigated. 
No significant correlations could be seen be- 
tween age, weight, HRS-D score and hormone 
values. 
Cortisol and ACTH values were not signifi- 
cantly correlated in patients with major depres- 
sive disorder (r = 0.387, P = 0.24, n = 12), but 
nearly reached statistical significance in controls 
(r = 0.520, P < 0.07, n = 13). Due to the in- 
creased number of cases it reached significance in 
the whole cohort of subjects (r = 0.45 1, P < 0.03, 
II = 25). 
TABLE 1 
DEMOGRAPHIC AND CLINICAL DATA OF THE 12 DEPRESSIVE PATIENTS STUDIED 
Age Sex DSM-IIIR 
(years) 
44 F 296.53 
66 F 296.33 
hl F 296.34 
64 F 296.33 
3’) F 296.33 
60 M 296.33 
ho M 2Yh.33 
34 F 296.33 
54 F 296.53 
1x F 296.23 
53 M 296.33 
34 F 296.33 
4x.7* 15.1 
ami, amitriptyline; map. maprotiline. 
HRS-D 
33 
36 
28 
28 
25 
24 
28 
28 
33 
26 
26 
39 
29.5 + 4.7 
Depressive 
episodes 
3 
2 
3 
4 
3 
3 
3 
3 
6 
1 
2 
3 
3.Of 1.2 
Drug-free 
period 
(days) 
> 2x 
> 28 
> 28 
> 28 
7 
5 
5 
4 
> 28 
> 2x 
> 21 
s 
Medication 
prior to drug- 
free period 
100 mg ami 
100 mg ami 
I50 mg map 
100 mg map 
150 mg ami 
Mean + SD 
TABLE 2 
HORMONE VALUES AND LYMPHOCYTE PROLIFER- 
ATIVE RESPONSE OF DEPRESSIVE PATIENTS AND 
CONTROLS 
Controls Patients 
(n = 13) (n = 12) 
Cortisol (pmol/l) 225.7 + 77.3 273.1 f 104.8 
ACTH (pmol/ll 3.6k 0.8 4.2+ 1.5 
Stimulation indices 
optimal 
10.0 Fg/ml PHA 28.0-t 5.0 23.4+ 3.9 
10.0 pg/ml Con A 15.li 2.4 14.7* 2.1 
10.0 pg/ml PWM 17.5* 3.1 21.9k 4.2 
non-optima1 
1.0 pg/ml PHA 9.2k 1.4 9.4+ 1.6 
1.0 fig/ml Con A 5.6k 0.9 4.0* 0.5 
1.0 kg/ml PWM 11.7k 2.4 15.9+ 2.7 
Stimulation index: ratio of lectin-stimulated to spontaneous 
cpm. 
Lectin-induced lymphocyte blastogenesis 
Table 2 shows the hormone values and lym- 
phocyte blastogenesis after stimulation with one 
optimal and one non-optimal concentration of 
each lectin. There was no statistically significant 
difference between depressed patients and con- 
trols in lymphocyte response to any concentration 
of the lectins tested. 
No significant correlations could be observed 
between the lymphocyte responses to PWM, Con 
A or PHA and age, weight, HRS-D score or 
cortisol values. Only lymphocyte blastogenesis af- 
ter stimulation with the non-optimal PHA con- 
centration (1.0 pg/ml) was significantly associ- 
ated with ACTH values in depressed patients 
(r = -0.66, P < 0.04). 
Sensitirity of lymphocyte blastogenesis to in ritro 
added dexamethasone 
In vitro added DEX produced a dose-depen- 
dent suppression of spontaneous, PHA- (Figs. 1, 
2) and Con A-induced lymphocyte proliferative 
responses (not shown) in patients and healthy 
controls. In vitro DEX administration exhibited 
no suppressive effect on PWM-stimulated blasto- 
genesis in either group (Fig. 3). 
In all subjects serum cortisol levels at 4.00 p.m. 
were significantly associated with the inhibitory 
potency of in vitro DEX on 1.0 pg/ml PHA- 
. contr 
q Pot 
IE-10 IE-9 lE-8 IE-7 lE-6 
Dexamethasone CM) 
Fig. 1. Effect of lo-‘“- 10mh M in vitro dexamethasone on 1.0 
pg/ml PHA-induced lymphocyte blastogenesis (arithmetic 
means+SD; all assays were performed in triplicate). After 
covarying out serum cortisol levels, the differences between 
healthy controls (n = 13) and depressive patients (n = 12) were 
statistically significant (P < 0.05; see Results for details). 
stimulated cells (Table 3). ACTH levels were only 
correlated with the inhibition of PHA-induced 
proliferation by lo- “-lo-” mol/l DEX (Table 
3). The results with 10.0 pg/ml PHA-stimulated 
cells are shown in Table 3. 
No significant correlations could be observed 
between levels of adrenal cortical hormones and 
DEX-induced inhibition of cells stimulated with 
optimal or non-optimal concentrations of Con A 
and PWM. 
Since the in vitro PHA-stimulated lymphocyte 
proliferative response was correlated with the in 
vivo hormone levels (Table 31, it seemed useful to 
r, Ttl 
IE-10 lE-9 lE-8 
I- 
IE-7 
1
n corer 
q Pat 
I 
IE-6 
Dexamethasone (MI 
Fig. 2. Effect of 10-“‘-lO~h M in vitro dexamethasone on 
10.0 pg/ml PHA-induced lymphocyte blastogenesis (arith- 
metic means*SD; all assays were performed in triplicate). 
The differences between healthy controls (n = 13) and depres- 
sive patients (n = 12) were statistically not significant. 
IE-9 lE-8 IE-7 
I 
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Dexomethosone CM 1 
Fig. 3. Effect of lo- “‘-10~’ M in vitro dexamethasone on 
10.0 pg/ml PWM-induced lymphocyte blastogenesis (arith- 
metic means+SD; all assays were performed in triplicate). 
The differences between healthy controls (n = 13) and depres- 
sive patients (n = 12) were statistically not significant. 
weigh this influence statistically. Therefore, indi- 
viduals’ in vitro lymphocyte proliferation was ad- 
justed for their in vivo cortisol levels (ANCOVA). 
This revealed that 1.0 pg/ml PHA-stimulated 
lymphocytes of depressed patients exhibited a 
significantly weaker suppression of blastogenesis 
after in vitro addition of 1O-8 mol/l (F = 4.49, 
PC 0.04), lo-’ mol/l (F= 6.09, P < 0.03) and 
lo-” mol/l DEX (F = 6.61, P < 0.02). The same 
results could be obtained after serum ACTH 
levels were covaried out (lo-” mol/l: F = 5.11, 
P < 0.04; lo-’ mol/l: F = 3.99, P< 0.05; lo-” 
mol/l DEX: F = 5.52, P < 0.03). Only a non-sig- 
nificant trend (P = 0.1) could be seen with 10.0 
pug/ml PHA-stimulated lymphocytes. 
TABLE 3 
CORRELATIONS (I) BETWEEN ACTH AND CORTISOL 
LEVELS AND PHA-STIMULATED LYMPHOCYTE 
BLASTOGENESIS 
DEX 1 .O pg/ml PHA 10.0 pg/ml PHA 
[mol/ll Cortisol ACTH Cortisol ACTH 
;;:b” 
-0.45 * ~ 0.52 * - 0.23 ~ 0.34 
-0.42 * -0.45 * ~ 0.32 -0.39 ** 
lomx - 0.44 * PO.37 ** ~ 0.26 -0.35 ** 
IO_’ - 0.50 * - 0.22 -0.39 ** -0.38 ** 
lomh -0.52 * - 0.34 -0.41 ** -0.37 ** 
N=25. 
* P < 0.05: **p < 0.1. 
No significant differences in DEX sensitivity 
of PWM- and Con A-stimulated lymphocytes 
could be detected between the two groups, even 
after covarying out the influence of in vivo hor- 
mone values. 
Discussion 
In accordance with Albrecht et al. (1985), 
Darko et al. (1989) and Schleifer et al. (1989) we 
were not able to corroborate previous findings of 
primarily impaired cell-mediated immunity in de- 
pressed patients by means of the lymphocyte 
transformation assay (Schleifer et al., 1984; Ca- 
labrese et al., 1986; Kronfol et al., 1986; Cosyns 
et al., 1989). There were no differences in PWM-, 
PHA- or Con A-induced proliferative responses 
between patients with major depressive disorder 
and healthy controls. 
Schleifer et al. (1989) attributed impaired 
lectin-induced lymphocyte blastogenesis to fac- 
tors such as age or severity of depression. How- 
ever, in accordance with other groups (Albrecht 
et al., 1985; Kronfol et al., 1986; Cosyns et al., 
1989) we were not able to confirm such an associ- 
ation. Moreover, in contrast to Schleifer et al. 
(19891, we could not observe a significant contri- 
bution of severity of depression, as assessed by 
the 21-item HRS-D, or of several independent 
variables, such as gender, age or weight. 
These discrepancies might be due to our rela- 
tively homogeneous and small group of severely 
depressed patients, as well as to differences in 
the methodology applied. 
Previous studies took blood samples in the 
morning hours, when the level of cortisol reaches 
its circadian peak (Ritchie et al., 1983). Glucocor- 
ticoid receptors are supposed to be down-regu- 
lated in the morning hours and up-regulated in 
the evening (Rupprecht et al., 1990). Therefore, 
glucocorticoid-induced effects might be more evi- 
dent when blood samples are taken in the after- 
noon hours. This also indicates that single-point 
measurements of circulating hormones might not 
exactly reflect the blood concentrations over the 
previous several hours, which primarily determine 
receptor sensitivity. 
The circadian variation of lymphocyte subpop- 
ulations is well established, as well as their differ- 
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ent sensitivity to glucocorticoids (Ritchie et al., 
1983). Moreover, stimulation of T lymphocyte 
subpopulations is thought to depend partly on the 
lectin and on the concentrations used (Dwyer and 
Johnson, 1981). Therefore, the circadian rhythm 
of T cell subsets in the peripheral blood and their 
different sensitivity to glucocorticoids might be a 
reason for the discrepant results after stimulation 
with the T cell mitogens PHA and Con A. 
Data in previous work (with the exception of 
Darko et al., 1989) have been expressed as stimu- 
lated (in the presence of lectin) cpm minus spon- 
taneous (in the absence of lectin) cpm. In con- 
trast, we analyzed lymphocyte proliferation in 
terms of a stimulation index, which weighs in 
vitro proliferation of in vivo stimulated cells more 
heavily and has a lower interassay coefficient of 
variation. 
Although our patients with major depressive 
disorder tended to have higher cortisol values 
than healthy controls, this did not reach statistical 
significance. In accordance with other investiga- 
tors (Albrecht et al., 1985; Kronfol et al., 1986) 
we were not able to observe a correlation be- 
tween primary in vitro lymphocyte blastogenesis 
and in vivo levels of adrenal cortical hormones. 
Interestingly, the DEX-induced inhibition of 
PHA-stimulated blastogenesis was inversely cor- 
related with adrenal cortical hormone values. 
Consequently, high levels of circulating cortisol in 
vivo result in a desensitization of the glucocorti- 
coid receptor. This supports previous findings 
from our and other laboratories that the gluco- 
corticoid receptor is under autoregulatory control 
in humans (Lowy et al., 1988; Rupprecht et al., 
1990). Moreover, after covarying out the influ- 
ence of in vivo hormone levels, PHA-stimulated 
lymphocytes of depressed patients exhibited an 
impaired sensitivity to pharmacological as well as 
physiological concentrations of in vitro glucocorti- 
coids. 
These results are partly in contrast to those of 
Lowy et al. (19881, who also described a weaker 
DEX-induced suppression of lymphocyte blasto- 
genesis, but only after stimulation with Con A. 
This discrepancy might be mainly attributed to 
the above-mentioned methodological differences 
(e.g., time of blood sampling and concentrations 
of lectins), as well as to differences in selection 
criteria of patients (e.g., dexamethasone suppres- 
sors and non-suppressors). 
Our data suggest that in depressed patients 
immune system integrity could usually be main- 
tained by adaptation to the endogenous hypercor- 
tisolemia. But this fragile new homeostasis might 
be difficult to maintain if additional disturbances 
occur (e.g., pharmacologically induced or physio- 
logical shifts of in vivo hormonal balance). This 
might further support the hypothesis of a gluco- 
corticoid receptor dysfunction in patients with 
major depressive disorder, since a variety of hor- 
mones are reported to be resistant to glucocorti- 
coid-induced changes during the acute phase of 
the disease, as well (Fang et al., 1981; Rupprecht 
et al., 1987, 1988). Moreover, some recent reports 
have described that antidepressants elicit an in- 
crease of glucocorticoid receptor mRNA and im- 
munoreactivity in neuronal cell cultures and in 
the locus coeruleus of rats (Pepin et al., 1989; 
Kitayama et al., 1988). 
In conclusion, the elucidation of the exact 
mechanism of impaired glucocorticoid sensitivity 
(i.e., abnormalities in glucocorticoid receptor ac- 
tivation, translocation, genomic interaction, ex- 
pression of proteins, etc.) may yield insights into 
the pathophysiology of major depressive disorder. 
Therefore, further analysis of glucocorticoid re- 
ceptor function (e.g., by means of in vivo and in 
vitro challenge studies) is needed to more clearly 
delineate the relationship among the hypothe- 
sized impaired receptor plasticity, derangement 
of HPA axis activity and major depressive disor- 
der. 
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